You are on Index, TNW's next generation data platform. Learn More »

2018-09-11

OncoResponse raised $40M in Venture capital (Series B)

Investors: Canaan Partners, Redmile Group, ARCH Venture Partners, +6

Stories on this investment

OncoResponse Raises $40M in Series B Financing

FinSMEs

OncoResponse grabs $40 mln Series B

PE HUB

OncoResponse Nabs $40M for Cancer Drugs Based On Survivors’ Antibodies

Xconomy
1 more story
Show all

OncoResponse raises $40M to start clinical trials of antibody-based cancer immunotherapies

GeekWire

OncoResponse Info

All investors